✦ LIBER ✦

Dalfampridine: A new agent for symptomatic management of multiple sclerosis

✍ Scribed by McDonald, S.; Clements, J. N.

Book ID: 120400826
Publisher: American Society of Health-System Pharmacists
Year: 2011
Tongue: English
Weight: 184 KB
Volume: 68
Category: Article
ISSN: 1079-2082
DOI: 10.2146/ajhp110134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dimethyl Fumarate (Tecfidera): A New Ora

Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis

✍ Venci, Jineane V. (author);Gandhi, Mona A. (author) 📂 Article 📅 2013 🏛 SAGE Publications Inc. 🌐 English ⚖ 298 KB

Dimethyl Fumarate (Tecfidera): A New Ora

Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis

✍ Venci, Jineane V. (author);Gandhi, Mona A. (author) 📂 Article 📅 2013 🏛 SAGE Publications Inc. 🌐 English ⚖ 298 KB

Response to Comment on "Dimethyl Fumarat

Response to Comment on "Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis"

✍ Venci, J.; Gandhi, M. A. 📂 Article 📅 2014 🏛 Harvey Whitney Books Company 🌐 English ⚖ 227 KB

Alemtuzumab for multiple sclerosis: a ne

Alemtuzumab for multiple sclerosis: a new age of immunotherapy

✍ Robertson, N. P. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 132 KB

LSN MS guidelines for the management of

LSN MS guidelines for the management of multiple sclerosis

✍ Shatila, A.R.; Koussa, S.; Jabbour, R.; Mourad, A.; Aouad, A.; Sabbagh, G.; Kall 📂 Article 📅 2013 🏛 Masson Editeur 🌐 English ⚖ 430 KB

Quantitative assessment of sustained-rel

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis

✍ Schwid, S. R.; Petrie, M. D.; McDermott, M. P.; Tierney, D. S.; Mason, D. H.; Go 📂 Article 📅 1997 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 640 KB